Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors;Allo-immunisation anti-RH1 (anti-D) après transfusion de concentrés plaquettaires issus de donneurs RH :1

Annales de Biologie Clinique

Volumn 67, Issue 3, 2009, Pages 353-357

  Duboeuf, S ^a   Flourie F ^a   Courbil, R ^a   Oriol, P ^b   Benamara, A ^a   Chartier, M ^a   Rigal, E ^a   Garraud, O ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Alloimmunization; Erythrocytes; Platelets; Rhesus; Transfusion

Indexed keywords

RHESUS D ANTIBODY;

AGED; ARTICLE; BLOOD GROUP RHESUS SYSTEM; CASE REPORT; ERYTHROCYTE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; THROMBOCYTE TRANSFUSION;

AGED; ERYTHROCYTES; FEMALE; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PLATELET TRANSFUSION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 70149096139     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2009.0336     Document Type: Article

References (13)

1. Afssaps. Transfusion de plaquettes : produits, indications. Recommandations. Agence française de sécurité sanitaire des produits de santé, juin 2003.
2. Menitove JE. Immunoprophylaxis for D- patients receiving platelet transfusions from D+ donors? Transfusion 2002; 42 : 136-8.
3. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972; 23 : 376-81.
4. Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000; 111 : 980-3.
5. Cid J, Ortin X, Elies E, Castellà D, Panadés M, Martín-Vega C. Absence of anti-D alloimmunization in hematologic patients after Dincompatible platelet transfusions. Transfusion 2002; 42 : 173-6.
6. Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases. Vox Sang 1983; 45 : 139-43.
7. Lichtiger B, Hester JP. Transfusion of Rh-incompatible blood components to cancer patients. Haematologia (Budap) 1986; 19 : 81-8.
8. Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002; 42 : 177-82.
9. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, et al. Platelet transfusion for patients with cancer : clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19 : 1519-38.
10. Chamouni P, Josset V, Bastit D, Tavolacci MP, Lenain P, Varin R, et al. Transfusions de concentrés plaquettaires Rhésus incompatible au CHU de Rouen : pratiques et conséquences. Transfus Clin Biol 2005; 12 : 306-12.
11. Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003; 17 : 57-68.
12. Haspel RL, Walsh L, Sloan SR. Platelet transfusion in an infant leading to formation of anti-D : implications for immunoprophylaxis. Transfusion 2004; 44 : 747-9.
13. Cid J, Lozano M. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Transfusion 2005; 45 : 453 (author reply : 453-4).